ST Pharm Co.,Ltd.

KOSDAQ:A237690 Voorraadrapport

Marktkapitalisatie: ₩1.7t

ST PharmLtd Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Mooje Sung

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.8yrs
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Should You Be Adding ST PharmLtd (KOSDAQ:237690) To Your Watchlist Today?

Nov 22
Should You Be Adding ST PharmLtd (KOSDAQ:237690) To Your Watchlist Today?

ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up

Aug 30
ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?

Aug 17
Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?

Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?

May 09
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?

Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

Mar 22
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Mar 18
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Mar 16
Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

Jan 22
Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Dec 23
What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

Nov 26
Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

CEO

Mooje Sung

less than a year

Tenure

Mooje Sung is Chief Executive Officer of ST Pharm Co. Ltd. from July 2024. Mooje Sung has Ph.D. in Organic Chemistry from University Of Alabama, M.S. in Organic Chemistry from Sogang University and has B.S...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Mooje Sung
Chief Executive Officerless than a yeargeen gegevensgeen gegevens
Dong-Ryul Lee
Head of Management Support Division & Inside Directorno datageen gegevensgeen gegevens
Seok-Woo Choi
Senior Vice Presidentno datageen gegevens0.00024%
₩ 4.0m
Hyunmin Lee
Senior Vice Presidentno datageen gegevensgeen gegevens
Jun Young Choi
Senior Vice President3.9yrsgeen gegevens0.054%
₩ 907.9m
Sunki Chang
Senior Vice President1.8yrsgeen gegevensgeen gegevens
Joosung Yang
Senior Vice President1.8yrsgeen gegevens0.085%
₩ 1.4b
Kyungyeon Kim
Senior VP & Head of Corporate Quality Divisionno datageen gegevensgeen gegevens

1.8yrs

Gemiddelde duur

Ervaren management: Het managementteam van A237690 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.